Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Ragosa currently holds 16,154 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Ragosa has been a net seller of KNSA stock. They have purchased $0 and sold $4.6M worth of shares.
Mark Ragosa's most recent insider trade was on Apr 7, 2026, when they sold 2,694 shares at $0.00 per share.
Mark Ragosa serves as Executive at Kiniksa Pharmaceuticals, Ltd. (KNSA). They have executed 74 insider transactions totaling $4.6M over their tenure at the company.
Mark Ragosa holds the position of Executive at Kiniksa Pharmaceuticals, Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Mark Ragosa has shown a selling trading pattern, with $0 in total purchases and $4.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Ragosa was on Dec 8, 2025, when they sold $1.8M worth of KNSA shares. This transaction involved 42,841 shares at $41.49 per share.
Mark Ragosa currently owns 16,154 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Ragosa's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Ragosa has 74 Form 4 filings on record as an insider at Kiniksa Pharmaceuticals, Ltd..
Set alerts for Mark Ragosa and 40,000+ other insiders.